Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1915) 1915
Publication (199) 199
Book Review (36) 36
Book Chapter (11) 11
Book / eBook (7) 7
Conference Proceeding (5) 5
Government Document (2) 2
Dissertation (1) 1
Magazine Article (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1285) 1285
index medicus (1110) 1110
oncology (772) 772
cancer (626) 626
female (562) 562
male (562) 562
middle aged (394) 394
recurrent (384) 384
aged (360) 360
adult (310) 310
animals (276) 276
care and treatment (251) 251
surgery (247) 247
chemotherapy (242) 242
research (242) 242
radiology, nuclear medicine & medical imaging (229) 229
tumors (224) 224
prostate cancer (220) 220
radiotherapy (212) 212
medicine & public health (211) 211
treatment outcome (194) 194
carcinoma (190) 190
health aspects (187) 187
analysis (165) 165
recurrent prostate-cancer (161) 161
aged, 80 and over (153) 153
article (145) 145
diagnosis (141) 141
prostate-cancer (140) 140
genetic aspects (139) 139
metastasis (138) 138
prognosis (135) 135
phase-ii trial (131) 131
therapy (130) 130
risk factors (128) 128
urology & nephrology (127) 127
retrospective studies (124) 124
expression (120) 120
pharmacology & pharmacy (117) 117
patients (114) 114
radiation-therapy (113) 113
survival (111) 111
review (109) 109
breast-cancer (108) 108
cell line, tumor (107) 107
clinical trials (106) 106
medicine, research & experimental (104) 104
mice (103) 103
hematology, oncology and palliative medicine (102) 102
genetics & heredity (100) 100
mutation (100) 100
phase-ii (100) 100
immunotherapy (98) 98
ovarian cancer (96) 96
radical prostatectomy (96) 96
medicine (93) 93
recurrence (93) 93
antineoplastic agents - therapeutic use (92) 92
cell lung-cancer (88) 88
medical research (88) 88
cell biology (85) 85
management (85) 85
prostate (85) 85
cancer therapies (84) 84
development and progression (84) 84
biochemistry & molecular biology (83) 83
gene expression (83) 83
neoplasms - drug therapy (83) 83
disease-free survival (82) 82
radiation therapy (82) 82
usage (81) 81
combined modality therapy (80) 80
follow-up studies (80) 80
genes (80) 80
diseases (79) 79
neoplasm staging (78) 78
positron-emission-tomography (76) 76
prostatic neoplasms - pathology (75) 75
glioblastoma (74) 74
relapse (74) 74
apoptosis (73) 73
clinical trials as topic (73) 73
recurrent glioblastoma (73) 73
breast cancer (72) 72
hematology (72) 72
immunology (72) 72
drug therapy (70) 70
biotechnology & applied microbiology (69) 69
neoplasm recurrence, local - pathology (69) 69
neoplasms - therapy (69) 69
recurrent prostate cancer (69) 69
brachytherapy (68) 68
squamous-cell carcinoma (68) 68
angiogenesis (67) 67
pathology (67) 67
proteins (67) 67
studies (67) 67
radiation (65) 65
survival analysis (65) 65
clinical neurology (64) 64
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1859) 1859
French (50) 50
German (17) 17
Spanish (6) 6
Japanese (2) 2
Russian (2) 2
Arabic (1) 1
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Prostate cancer
by Brenot-Rossi, I and Salaun, PY
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, ISSN 0928-1258, 01/2019, Volume 43, Issue 1, pp. 77 - 84
C-11-CHOLINE PET-CT | PSA DOUBLING TIME | F-18-CHOLINE PET/CT | POSITRON-EMISSION-TOMOGRAPHY | CURATIVE TREATMENT | BIOCHEMICAL RECURRENCE | CHOLINE-PET/CT | RADICAL PROSTATECTOMY | F-18-FLUOROCHOLINE PET/CT | PATHOLOGY | RADIATION-THERAPY
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Magnetic nanoparticle hyperthermia for prostate cancer
by Johannsen, Manfred and Thiesen, Burghard and Wust, Peter and Jordan, Andreas
International Journal of Hyperthermia, ISSN 0265-6736, 12/2010, Volume 26, Issue 8, pp. 790 - 795
Magnetic nanoparticles are increasingly used for clinical applications such as drug delivery, magnetic resonance imaging and magnetic fluid hyperthermia. A... 
magnetic fluid | thermotherapy | hyperthermia | prostate cancer | nanoparticles | Nanoparticles | Magnetic fluid | Thermotherapy | Hyperthermia | Prostate cancer | REGIONAL HYPERTHERMIA | CARCINOMA CELLS | FEASIBILITY | RADIATION | RAT MODEL | EXTERNAL-BEAM RADIOTHERAPY | IN-VITRO | ONCOLOGY | RECURRENT | FLUID HYPERTHERMIA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Nanoparticles - therapeutic use | Humans | Brachytherapy - methods | Male | Hyperthermia, Induced - methods | Magnetics | Clinical Trials, Phase I as Topic | Prostatic Neoplasms - therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text PSMA PET/CT with Glu-urea-Lys-(Ahx)-[68Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer
by Giesel, Frederik L and Fiedler, H and Stefanova, M and Sterzing, F and Rius, M and Kopka, K and Moltz, J H and Afshar-Oromieh, A and Choyke, P L and Haberkorn, U and Kratochwil, C
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 11/2015, Volume 42, Issue 12, pp. 1794 - 1800
PET/CT with the PSMA ligand is a powerful new method for the early detection of nodal metastases in patients with biochemical relapse. The purpose of this... 
Lymph node metastasis | Medicine & Public Health | Orthopedics | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | 68 Ga-PSMA-11 PET/CT | Recurrent prostate cancer | Lymph node evaluation | Ga-PSMA-11 PET/CT | ANDROGEN RECEPTOR | DIAGNOSIS | MEMBRANE ANTIGEN | MRI | COMPUTERIZED-TOMOGRAPHY | METASTASES | Ga-68-PSMA-11 PET/CT | THERAPY | DISSECTION | LIGAND | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Prostatic Neoplasms - pathology | Recurrence | Oligopeptides | Humans | Middle Aged | Male | Lymphatic Metastasis | Positron-Emission Tomography | Prostatic Neoplasms - diagnosis | Edetic Acid - analogs & derivatives | Radiography | Multimodal Imaging | Prostatic Neoplasms - diagnostic imaging | Aged | Retrospective Studies | Imaging, Three-Dimensional | Urea | Relapse | PET imaging | Prostate cancer | Diseases | Tomography | Lymphatic system | Medical imaging | Metastasis | 68Ga-PSMA-11 PET | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer
by Soyka, Jan D and Muster, Marco A and Schmid, Daniel T and Seifert, Burkhardt and Schick, Ulrike and Miralbell, Raymond and Jorcano, Sandra and Zaugg, Kathrin and Seifert, Hans-Helge and Veit-Haibach, Patrick and Strobel, Klaus and Schaefer, Niklaus G and Husarik, Daniela B and Hany, Thomas F
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 6/2012, Volume 39, Issue 6, pp. 936 - 943
To investigate the clinical value of 18F-fluorocholine PET/CT (CH-PET/CT) in treatment decisions in patients with recurrent prostate cancer (rPCA).The study... 
Medicine & Public Health | Orthopedics | Oncology | 18 F-Choline PET/CT | Clinical impact | Nuclear Medicine | Cardiology | Imaging / Radiology | Recurrent prostate cancer | F-Choline PET/CT | Prostatic Neoplasms - metabolism | Recurrence | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Positron-Emission Tomography | Prostatic Neoplasms - therapy | Multimodal Imaging | Choline - analogs & derivatives | Prostatic Neoplasms - diagnostic imaging | Adult | Aged | Prostate-Specific Antigen - metabolism | Retrospective Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer
by Mark A. Titus and Michael J. Schell and Fred B. Lih and Kenneth B. Tomer and James L. Mohler
Clinical Cancer Research, ISSN 1078-0432, 07/2005, Volume 11, Issue 13, pp. 4653 - 4657
Purpose: Prostate cancer eventually recurs during androgen deprivation therapy despite castrate levels of serum androgens. Expression of androgen receptor and... 
electrospray mass spectrometry | Hormone synthesis, metabolism, and inhibitors | androgen | Proteomics, Mass Spectrometry, and Chemical Biology | recurrent prostate cancer | Genitourinary cancers: prostate | AMPLIFICATION | PROTEIN | METABOLISM | ONCOLOGY | ENDOCRINE-THERAPY | METASTASES | RECEPTOR GENE | EXPRESSION | BICALUTAMIDE | PROGRESSION | ANDROGEN DEPRIVATION THERAPY | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Chromatography, High Pressure Liquid - methods | Humans | Middle Aged | Neoplasm Recurrence, Local | Male | Dihydrotestosterone - analysis | Neoplasm Metastasis | Spectrometry, Mass, Electrospray Ionization - methods | Testosterone - analysis | Survival Analysis | Aged, 80 and over | Aged | Radioimmunoassay - methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Robotic Image-Guided Stereotactic Radiotherapy, for Isolated Recurrent Primary, Lymph Node or Metastatic Prostate Cancer
by Jereczek-Fossa, Barbara Alicja, M.D., Ph.D and Beltramo, Giancarlo, M.D and Fariselli, Laura, M.D and Fodor, Cristiana, M.Sc and Santoro, Luigi, M.Sc and Vavassori, Andrea, M.D and Zerini, Dario, M.D and Gherardi, Federica, M.D and Ascione, Carmen, M.D and Bossi-Zanetti, Isa, M.D and Mauro, Roberta, M.D and Bregantin, Achille, M.Sc and Bianchi, Livia Corinna, M.D and De Cobelli, Ottavio, M.D and Orecchia, Roberto, M.D
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 2, pp. 889 - 897
Purpose To evaluate the outcome of robotic CyberKnife (Accuray, Sunnyvale, CA)–based stereotactic radiotherapy (CBK-SRT) for isolated recurrent primary, lymph... 
Radiology | Hematology, Oncology and Palliative Medicine | Robotic stereotactic radiotherapy | Lymph node recurrence | Recurrent prostate cancer | Stereotactic radiotherapy | CRITERIA | MANAGEMENT | BODY RADIOTHERAPY | RADIOSURGERY | TOXICITY | RADIATION-THERAPY | ONCOLOGY | EXTERNAL-BEAM IRRADIATION | BRACHYTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Organs at Risk - radiation effects | Fiducial Markers | Lymph Nodes - surgery | Humans | Middle Aged | Male | Tomography, X-Ray Computed | Femur Head - radiation effects | Positron-Emission Tomography | Neoplasm Recurrence, Local - surgery | Radiosurgery - adverse effects | Urinary Bladder - radiation effects | Feasibility Studies | Neoplasm Recurrence, Local - diagnostic imaging | Multimodal Imaging - methods | Aged, 80 and over | Prostatic Neoplasms - blood | Prostatic Neoplasms - diagnostic imaging | Radiosurgery - methods | Neoplasm Recurrence, Local - blood | Urethra - radiation effects | Prostatic Neoplasms - drug therapy | Radiotherapy Dosage | Prostatic Neoplasms - pathology | Prostatic Neoplasms - surgery | Lymphatic Metastasis | Rectum - radiation effects | Tumor Burden | Prostate-Specific Antigen - blood | Disease-Free Survival | Radiotherapy, Image-Guided - methods | Choline | Androgen Antagonists - therapeutic use | Robotics - methods | Aged | Retreatment - methods | Carbon Radioisotopes | Radiotherapy | Prostate cancer | Metastasis | Index Medicus | PROSTATE | PATIENTS | NEOPLASMS | CHOLINE | LYMPH NODES | RECTUM | STABILIZATION | METASTASES | ANTIGENS | RADIATION DOSES | POSITRON COMPUTED TOMOGRAPHY | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | ANDROGENS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Ga-68-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
by Ceci, F and Uprimny, C and Nilica, B and Geraldo, L and Kendler, D and Kroiss, A and Bektic, J and Horninger, W and Lukas, P and Decristoforo, C and Castellucci, P and Fanti, S and Virgolini, I
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 07/2015, Volume 42, Issue 8, pp. 1284 - 1294
Purpose To assess the association between PSA levels, PSA kinetics and other factors and a pathological Ga-68-PSMA PET/CT scan in patients with recurrent... 
SURVIVAL | GA-68-LABELED PSMA LIGAND | DIAGNOSIS | Salvage radiotherapy | EAU GUIDELINES | RADICAL PROSTATECTOMY | RADIATION-THERAPY | Biochemical relapse | C-11-CHOLINE PET/CT | Ga-68-PSMA PET/CT | PSA doubling time | RADIOTHERAPY | SCAN | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Recurrent prostate cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text 68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
by Ceci, Francesco and Uprimny, Christian and Nilica, Bernhard and Geraldo, Llanos and Kendler, Dorota and Kroiss, Alexander and Bektic, Jasmin and Horninger, Wolfgang and Lukas, Peter and Decristoforo, Clemens and Castellucci, Paolo and Fanti, Stefano and Virgolini, Irene J
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 7/2015, Volume 42, Issue 8, pp. 1284 - 1294
To assess the association between PSA levels, PSA kinetics and other factors and a pathological 68Ga-PSMA PET/CT scan in patients with recurrent prostate... 
68 Ga-PSMA PET/CT | Biochemical relapse | Salvage radiotherapy | Medicine & Public Health | Orthopedics | PSA doubling time | Oncology | Nuclear Medicine | Imaging / Radiology | Cardiology | Recurrent prostate cancer | Ga-PSMA PET/CT
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Salvage surgery for nodal recurrent prostate cancer
by Bandini, Marco and Fossati, Nicola and Briganti, Alberto
Current Opinion in Urology, ISSN 0963-0643, 11/2017, Volume 27, Issue 6, pp. 604 - 611
PURPOSE OF REVIEWTo critically review the currently available literature regarding detection of nodal recurrent prostate cancer (PCa) and to examine the role... 
lymphatic metastases | nodal recurrent | salvage lymph node dissection | prostate cancer | adjuvant therapy | salvage surgery | lymphadenectomy | BIOCHEMICAL RECURRENCE | DISSECTION | CONFORMAL RADIOTHERAPY | EMISSION TOMOGRAPHY/COMPUTERIZED TOMOGRAPHY | RADICAL RETROPUBIC PROSTATECTOMY | PET/CT | HBED-CC | UROLOGY & NEPHROLOGY | PSA FAILURE | ESTRO-SIOG GUIDELINES | Lymph Node Excision | Prostatic Neoplasms - pathology | Prospective Studies | Prostatic Neoplasms - surgery | Humans | Salvage Therapy | Male | Tomography, X-Ray Computed | Lymphatic Metastasis | Positron-Emission Tomography | Neoplasm Recurrence, Local - surgery | Multimodal Imaging | Antigens, Surface | Glutamate Carboxypeptidase II
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Application of 11C‐acetate positron‐emission tomography (PET) imaging in prostate cancer: systematic review and meta‐analysis of the literature
by Mohsen, Beheshti and Giorgio, Treglia and Rasoul, Zakavi Seyed and Werner, Langsteger and Ali, Ghodsi Rad Mohammad and Reza, Dabbagh Kakhki Vahid and Ramin, Sadeghi
BJU International, ISSN 1464-4096, 12/2013, Volume 112, Issue 8, pp. 1062 - 1072
To review the literature on the application of 11C‐acetate positron‐emission tomography (PET) imaging in prostate cancer. We systematically reviewed the... 
prostate cancer | 11C‐acetate | meta‐analysis | systematic review | PET | C-acetate | meta-analysis | DIAGNOSTIC-TEST | PSA RELAPSE | LOCALIZATION | MRI | 18F-FLUOROCHOLINE | RADICAL PROSTATECTOMY | RECURRENT DISEASE | UROLOGY & NEPHROLOGY | C-11-ACETATE PET | CARCINOMA | C-11-acetate | FDG PET | Pets | PET imaging | Prostate cancer | Acetates | Studies | Tomography | Medical imaging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer
by Wadosky, Kristine M and Koochekpour, Shahriar
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 39, pp. 64447 - 64470
Prostate cancer (PCa) is the most widely diagnosed male cancer in the Western World and while low-and intermediate-risk PCa patients have a variety of... 
ADT | Splice variant | Castrate-recurrent | Prostate cancer | Androgen receptor | STEROID-BINDING CHARACTERISTICS | ANION-TRANSPORTING POLYPEPTIDES | IN-SITU HYBRIDIZATION | RADICAL PROSTATECTOMY | MISMATCH REPAIR | CELL-GROWTH | SPLICE VARIANTS | CELL BIOLOGY | prostate cancer | MITOXANTRONE PLUS PREDNISONE | androgen receptor | DNA-REPAIR DEFECTS | castrate-recurrent | RECEPTOR GENE | splice variant | Phosphorylation | Prostatic Neoplasms, Castration-Resistant - blood | Humans | Receptors, Androgen - metabolism | Risk Factors | Male | Treatment Outcome | Prostatic Neoplasms, Castration-Resistant - drug therapy | Prostate-Specific Antigen - blood | Prostatic Neoplasms, Castration-Resistant - genetics | Prostatic Neoplasms, Castration-Resistant - pathology | Antineoplastic Agents, Hormonal - adverse effects | Drug Resistance, Neoplasm - genetics | Animals | Receptors, Androgen - drug effects | Receptors, Androgen - genetics | Signal Transduction - drug effects | Antineoplastic Agents, Hormonal - therapeutic use | Androgen Antagonists - therapeutic use | Kallikreins - blood | Mutation | Androgen Antagonists - adverse effects | Neoplasm Staging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Clinical impact of F-18-choline PET/CT in patients with recurrent prostate cancer
by Soyka, JD and Muster, MA and Schmid, DT and Seifert, B and Schick, U and Miralbell, R and Jorcano, S and Zaugg, K and Seifert, HH and Veit-Haibach, P and Strobel, K and Schaefer, NG and Husarik, DB and Hany, TF
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 06/2012, Volume 39, Issue 6, pp. 936 - 943
To investigate the clinical value of F-18-fluorocholine PET/CT (CH-PET/CT) in treatment decisions in patients with recurrent prostate cancer (rPCA). The study... 
F-18-CholinePET/CT | C-11-CHOLINE PET/CT | BIOCHEMICAL RECURRENCE | F-18-FLUOROCHOLINE | DISEASE | Clinical impact | RADICAL PROSTATECTOMY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Recurrent prostate cancer | PSA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Deep Recurrent Neural Networks for Prostate Cancer Detection: Analysis of Temporal Enhanced Ultrasound
by Azizi, Shekoofeh and Bayat, Sharareh and Yan, Pingkun and Tahmasebi, Amir and Kwak, Jin Tae and Xu, Sheng and Turkbey, Baris and Choyke, Peter and Pinto, Peter and Wood, Bradford and Mousavi, Parvin and Abolmaesumi, Purang
IEEE Transactions on Medical Imaging, ISSN 0278-0062, 12/2018, Volume 37, Issue 12, pp. 2695 - 2703
Temporal enhanced ultrasound (TeUS), comprising the analysis of variations in backscattered signals from a tissue over a sequence of ultrasound frames, has... 
deep learning | Ultrasonic imaging | Recurrent neural networks | cancer detection | recurrent neural network | Biopsy | Logic gates | Prostate cancer | Temporal enhanced ultrasound | Principal component analysis | long short-term memory | prostate cancer | DIAGNOSIS | FUSION | ENGINEERING, BIOMEDICAL | BIOPSY | CLASSIFICATION | IMAGING SCIENCE & PHOTOGRAPHIC TECHNOLOGY | long short-termmemory | ENGINEERING, ELECTRICAL & ELECTRONIC | COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS | MULTI-PARAMETRIC MRI | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Algorithms | Humans | Image Interpretation, Computer-Assisted - methods | Prostate - diagnostic imaging | Ultrasonography | Prostatic Neoplasms - diagnostic imaging | Male | Deep Learning | Networks | Backscattering | Tissues | Accuracy | Neural networks | In vivo methods and tests | Short term memory | Prostate | Ultrasound | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text ERG rearrangement is specific to prostate cancer and does not occur in any other common tumor
by Scheble, Veit J and Braun, Martin and Beroukhim, Rameen and Mermel, Craig H and Ruiz, Christian and Wilbertz, Theresia and Stiedl, Ann-Cathrin and Petersen, Karen and Reischl, Markus and Kuefer, Rainer and Schilling, David and Fend, Falko and Kristiansen, Glen and Meyerson, Matthew and Rubin, Mark A and Bubendorf, Lukas and Perner, Sven
Modern Pathology, ISSN 0893-3952, 08/2010, Volume 23, Issue 8, pp. 1061 - 1067
Identification of specific somatic gene alterations is crucial for the insight into the development, progression, and clinical behavior of individual cancer... 
carcinoma | prostate cancer | ERG rearrangement | HETEROGENEITY | TMPRSS2/ERG FUSION GENE | TMPRSS2-ERG FUSION | RECURRENT FUSION | CARCINOMAS | PATHOLOGY | EXPRESSION | EVENT | Transcriptional Regulator ERG | Tissue Array Analysis | Humans | In Situ Hybridization, Fluorescence | Male | Oncogene Proteins, Fusion | Prostatic Neoplasms - genetics | DNA Mutational Analysis | Gene Deletion | Gene Rearrangement | Trans-Activators - genetics | Female | Adenocarcinoma - genetics | DNA, Neoplasm - analysis | Polymorphism, Single Nucleotide | Serine Endopeptidases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text PET/MRI Evaluation of Gynecologic Malignancies and Prostate Cancer
by Bagade, Swapnil, MD and Fowler, Kathryn J., MD and Schwarz, Julie K., MD, PhD and Grigsby, Perry W., MD and Dehdashti, Farrokh, MD
Seminars in Nuclear Medicine, ISSN 0001-2998, 2015, Volume 45, Issue 4, pp. 293 - 303
PET combined with cross-sectional anatomical imaging is an essential part of workup for most malignancies, in which CT or MRI provides anatomical context to... 
Radiology | DIFFUSION-WEIGHTED MRI | FDG-PET | LYMPH-NODE METASTASIS | UTERINE CORPUS CANCER | EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY | INTEGRATED WHOLE-BODY | RECURRENT OVARIAN-CANCER | CERVICAL-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | ENDOMETRIAL CANCER | DIAGNOSTIC PERFORMANCE | Genital Neoplasms, Female - diagnosis | Humans | Multimodal Imaging - methods | Genital Neoplasms, Female - diagnostic imaging | Magnetic Resonance Imaging - methods | Prostatic Neoplasms - diagnostic imaging | Female | Male | Positron-Emission Tomography - methods | Prostatic Neoplasms - diagnosis | Medical colleges | Prostate cancer | Diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Emerging treatments for recurrent prostate cancer
by Hanna, Catherine and Jones, Robert J
Future Oncology, ISSN 1479-6694, 11/2015, Volume 11, Issue 21, pp. 2873 - 2880
Despite radical treatment, many men with prostate cancer will develop recurrence of their disease. In an exciting era of new therapies for prostate cancer in... 
docetaxel | relapse | immunotherapy | radiotherapy | prostatectomy | cancer | prostate | cryotherapy | salvage | recurrent | BIOCHEMICAL RECURRENCE | RANDOMIZED CONTROLLED-TRIAL | RADIATION-THERAPY | ANDROGEN-DEPRIVATION THERAPY | EXTERNAL-BEAM RADIOTHERAPY | ONCOLOGY | SALVAGE RADICAL PROSTATECTOMY | DISEASE RECURRENCE | INTENSITY FOCUSED ULTRASOUND | ADJUVANT RADIOTHERAPY | OF-THE-LITERATURE
Journal Article
Details down arrow
17. Biology of Castration-Recurrent Prostate Cancer
by Azzouni, Faris and Mohler, James
Urologic Clinics of North America, ISSN 0094-0143, 11/2012, Volume 39, Issue 4, pp. 435 - 452
Although androgen-deprivation therapy is the standard therapy for advanced and metastatic prostate cancer, this treatment is only palliative. Prostate cancer... 
Castration resistant | Biology | Castration recurrent | Prostate cancer | Mechanism | ANDROGEN-RECEPTOR GENE | TYROSINE PHOSPHORYLATION | NUCLEAR RECEPTOR | HUMAN LNCAP CELLS | INDEPENDENT GROWTH | DEPRIVATION THERAPY | CIRCULATING TUMOR-CELLS | EPIDERMAL-GROWTH-FACTOR | IN-VIVO | UROLOGY & NEPHROLOGY | LIGAND-BINDING DOMAIN | Prostatic Neoplasms - metabolism | Prostatic Neoplasms - pathology | Humans | Testosterone - biosynthesis | Male | Prostatic Neoplasms - physiopathology | Neoplasm Recurrence, Local - physiopathology | Neoplasms, Hormone-Dependent - physiopathology | Protein Isoforms - physiology | Neoplasm Recurrence, Local - pathology | Gene Amplification | Prostatic Neoplasms - genetics | Receptors, Androgen - drug effects | Receptors, Androgen - biosynthesis | Androgen Antagonists - therapeutic use | Antineoplastic Agents - pharmacology | Transcriptional Activation - physiology | Prostate - chemistry | Gene Expression Regulation, Neoplastic - physiology | Receptors, Androgen - physiology | Prostatic Neoplasms - drug therapy
Journal Article
Details down arrow
18. Full Text Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer
by Matthew I. Milowsky and David M. Nanus and Lale Kostakoglu and Shankar Vallabhajosula and Stanley J. Goldsmith and Neil H. Bander
Journal of Clinical Oncology, ISSN 0732-183X, 07/2004, Volume 22, Issue 13, pp. 2522 - 2531
Purpose To determine the maximum-tolerated dose (MTD), toxicity, human antihuman antibody (HAHA) response, pharmacokinetics, organ dosimetry, targeting, and... 
CAPROMAB PENDETIDE | THERAPY | ONCOLOGY | RECURRENT | RADIOIMMUNOTHERAPY | EXTRACELLULAR DOMAIN | LYMPHOMA | RADICAL PROSTATECTOMY | EXPRESSION | HYDROLASE | XENOGRAFTS | Yttrium Radioisotopes - adverse effects | Glutamate Carboxypeptidase II - immunology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - pharmacokinetics | Antibodies, Monoclonal - therapeutic use | Drug Resistance, Neoplasm | Male | Yttrium Radioisotopes - pharmacokinetics | Disease Progression | Prostatic Neoplasms - therapy | Maximum Tolerated Dose | Androgens - pharmacology | Radionuclide Imaging | Aged, 80 and over | Prostatic Neoplasms - diagnostic imaging | Aged | Antigens, Surface - immunology | Yttrium Radioisotopes - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights